Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral reduction techniques: types and purpose.

G Fischer1, W K Hoots, C Abrams

  • 1Biosynexus, Inc., Rockville, MD 20850, USA.

Transfusion Medicine Reviews
|July 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Creating a Healthy Ship.

Journal of the Royal Naval Medical Service·2018
Same author

The Food and Drug Administration's perspective on plasma safety.

Transfusion medicine reviews·2001
Same author

The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.

Transfusion medicine reviews·2001
Same author

Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison.

Diabetic medicine : a journal of the British Diabetic Association·2000
Same author

Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2000
Same author

ADH-associated pathologies. Diabetes insipidus and syndrome of inappropriate ADH.

MLO: medical laboratory observer·2000
Same journal

Assessment of CTLA-4, LAG-3, and TIM-3 Expression in Pediatric Patients With β-Thalassemia Major and Their Association With Alloimmunization.

Transfusion medicine reviews·2026
Same journal

A Reply to "Beyond Implementation: The Need for Validation, Equity, and Real-World Accountability in AI for Transfusion Medicine".

Transfusion medicine reviews·2026
Same journal

Beyond Implementation: The Need for Validation, Equity, and Real-World Accountability in AI for Transfusion Medicine.

Transfusion medicine reviews·2026
Same journal

Trust Over Knowledge: Rethinking Donor Iron Supplementation Strategies in Modern Blood Services-Authors' reply.

Transfusion medicine reviews·2026
Same journal

The Effect of Stress Ball and Music on Anxiety, Distress, and Pain Levels During Platelet Apheresis Donation: Randomized Controlled Trial.

Transfusion medicine reviews·2026
Same journal

Therapeutic Plateletpheresis for Thrombocytosis: Critical Analytic Reviews and Original Multicenter Experience.

Transfusion medicine reviews·2026
See all related articles

Plasma-product safety relies on viral reduction techniques. Continuous vigilance and development of new methods are crucial to address emerging pathogens and ensure product integrity against both enveloped and non-enveloped viruses.

Area of Science:

  • Biotechnology
  • Pharmaceutical Safety
  • Virology

Background:

  • Plasma-derived medicinal products require stringent viral safety measures.
  • Emerging pathogens and global travel necessitate ongoing refinement of viral reduction strategies.
  • Current screening methods like polymerase chain reaction complement, but do not replace, dedicated viral reduction techniques.

Purpose of the Study:

  • To review current viral reduction techniques used in plasma product manufacturing.
  • To discuss the ongoing importance of viral reduction in the context of evolving threats.
  • To explore future directions and regulatory landscapes for viral reduction.

Main Methods:

  • Comprehensive literature review of online and printed resources.
  • Assessment of established viral reduction methods including heat treatment, solvent/detergent, pH adjustment, and ultrafiltration.

Related Experiment Videos

  • Evaluation of complementary techniques like chromatography and fractionation steps.

    • Main Results:

    • Current techniques have varying impacts on product integrity and efficacy against different virus types.
    • Regulatory guidelines in the US and Europe recommend using at least two distinct viral reduction methods per product.
    • Validation studies demonstrate the effectiveness of combined approaches against both enveloped and non-enveloped viruses.

    Conclusions:

    • A multi-pronged approach using at least two viral reduction techniques with different mechanisms is essential for robust plasma product safety.
    • Continued innovation in viral reduction technologies is necessary to adapt to new and emerging viral threats.
    • Adherence to regulatory guidelines and thorough validation are critical for ensuring the safety of plasma-derived therapies.